nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—blood vessel—Behcet's disease	0.0427	0.0649	CbGeAlD
Loperamide—CALM2—pons—Behcet's disease	0.0286	0.0435	CbGeAlD
Loperamide—CALM1—pons—Behcet's disease	0.0285	0.0433	CbGeAlD
Loperamide—POMC—brainstem—Behcet's disease	0.0233	0.0355	CbGeAlD
Loperamide—CACNA1A—brainstem—Behcet's disease	0.0223	0.0339	CbGeAlD
Loperamide—POMC—skin of body—Behcet's disease	0.0198	0.03	CbGeAlD
Loperamide—POMC—medulla oblongata—Behcet's disease	0.0163	0.0247	CbGeAlD
Loperamide—CACNA1A—medulla oblongata—Behcet's disease	0.0155	0.0236	CbGeAlD
Loperamide—CALM2—artery—Behcet's disease	0.015	0.0227	CbGeAlD
Loperamide—CALM1—artery—Behcet's disease	0.0149	0.0226	CbGeAlD
Loperamide—POMC—midbrain—Behcet's disease	0.0149	0.0226	CbGeAlD
Loperamide—POMC—spinal cord—Behcet's disease	0.0145	0.022	CbGeAlD
Loperamide—CALM2—endothelium—Behcet's disease	0.0126	0.0192	CbGeAlD
Loperamide—CALM1—endothelium—Behcet's disease	0.0126	0.0191	CbGeAlD
Loperamide—POMC—nervous system—Behcet's disease	0.0122	0.0186	CbGeAlD
Loperamide—POMC—central nervous system—Behcet's disease	0.0118	0.0179	CbGeAlD
Loperamide—CACNA1A—nervous system—Behcet's disease	0.0117	0.0177	CbGeAlD
Loperamide—CALM2—blood vessel—Behcet's disease	0.0117	0.0177	CbGeAlD
Loperamide—CALM1—blood vessel—Behcet's disease	0.0116	0.0176	CbGeAlD
Loperamide—CACNA1A—central nervous system—Behcet's disease	0.0112	0.0171	CbGeAlD
Loperamide—CALM2—mouth—Behcet's disease	0.00976	0.0148	CbGeAlD
Loperamide—CALM1—mouth—Behcet's disease	0.00971	0.0148	CbGeAlD
Loperamide—POMC—brain—Behcet's disease	0.00934	0.0142	CbGeAlD
Loperamide—CACNA1A—brain—Behcet's disease	0.00892	0.0136	CbGeAlD
Loperamide—OPRM1—brainstem—Behcet's disease	0.00878	0.0133	CbGeAlD
Loperamide—CALM3—eye—Behcet's disease	0.0079	0.012	CbGeAlD
Loperamide—CALM3—retina—Behcet's disease	0.00783	0.0119	CbGeAlD
Loperamide—OPRD1—nervous system—Behcet's disease	0.00675	0.0103	CbGeAlD
Loperamide—OPRD1—central nervous system—Behcet's disease	0.0065	0.00987	CbGeAlD
Loperamide—OPRK1—nervous system—Behcet's disease	0.00647	0.00983	CbGeAlD
Loperamide—CALM2—brainstem—Behcet's disease	0.00637	0.00968	CbGeAlD
Loperamide—CALM1—brainstem—Behcet's disease	0.00634	0.00964	CbGeAlD
Loperamide—CALM3—mammalian vulva—Behcet's disease	0.00627	0.00953	CbGeAlD
Loperamide—OPRK1—central nervous system—Behcet's disease	0.00623	0.00946	CbGeAlD
Loperamide—CALM2—eye—Behcet's disease	0.0062	0.00943	CbGeAlD
Loperamide—CALM1—eye—Behcet's disease	0.00618	0.00938	CbGeAlD
Loperamide—CALM2—retina—Behcet's disease	0.00615	0.00934	CbGeAlD
Loperamide—CALM1—retina—Behcet's disease	0.00612	0.0093	CbGeAlD
Loperamide—CALM3—cardiac atrium—Behcet's disease	0.006	0.00912	CbGeAlD
Loperamide—CALM3—medulla oblongata—Behcet's disease	0.00566	0.0086	CbGeAlD
Loperamide—OPRM1—midbrain—Behcet's disease	0.0056	0.0085	CbGeAlD
Loperamide—OPRM1—spinal cord—Behcet's disease	0.00546	0.0083	CbGeAlD
Loperamide—CALM2—skin of body—Behcet's disease	0.0054	0.0082	CbGeAlD
Loperamide—CALM1—skin of body—Behcet's disease	0.00537	0.00816	CbGeAlD
Loperamide—CALM3—midbrain—Behcet's disease	0.00517	0.00786	CbGeAlD
Loperamide—OPRD1—brain—Behcet's disease	0.00516	0.00784	CbGeAlD
Loperamide—CALM3—spinal cord—Behcet's disease	0.00505	0.00767	CbGeAlD
Loperamide—OPRK1—brain—Behcet's disease	0.00494	0.00751	CbGeAlD
Loperamide—CALM2—mammalian vulva—Behcet's disease	0.00492	0.00748	CbGeAlD
Loperamide—CALM1—mammalian vulva—Behcet's disease	0.0049	0.00745	CbGeAlD
Loperamide—CALM2—cardiac atrium—Behcet's disease	0.00471	0.00716	CbGeAlD
Loperamide—CALM1—cardiac atrium—Behcet's disease	0.00469	0.00713	CbGeAlD
Loperamide—ABCB1—blood vessel—Behcet's disease	0.00463	0.00704	CbGeAlD
Loperamide—OPRM1—nervous system—Behcet's disease	0.0046	0.00699	CbGeAlD
Loperamide—CALM2—medulla oblongata—Behcet's disease	0.00444	0.00675	CbGeAlD
Loperamide—OPRM1—central nervous system—Behcet's disease	0.00443	0.00673	CbGeAlD
Loperamide—CALM1—medulla oblongata—Behcet's disease	0.00442	0.00672	CbGeAlD
Loperamide—CALM2—midbrain—Behcet's disease	0.00406	0.00617	CbGeAlD
Loperamide—CALM1—midbrain—Behcet's disease	0.00404	0.00614	CbGeAlD
Loperamide—CYP2B6—skin of body—Behcet's disease	0.00401	0.0061	CbGeAlD
Loperamide—CALM2—spinal cord—Behcet's disease	0.00396	0.00602	CbGeAlD
Loperamide—CALM1—spinal cord—Behcet's disease	0.00394	0.00599	CbGeAlD
Loperamide—CYP2D6—brainstem—Behcet's disease	0.00352	0.00535	CbGeAlD
Loperamide—OPRM1—brain—Behcet's disease	0.00352	0.00534	CbGeAlD
Loperamide—CALM2—nervous system—Behcet's disease	0.00334	0.00507	CbGeAlD
Loperamide—CALM1—nervous system—Behcet's disease	0.00332	0.00505	CbGeAlD
Loperamide—CALM3—brain—Behcet's disease	0.00325	0.00494	CbGeAlD
Loperamide—CALM2—central nervous system—Behcet's disease	0.00321	0.00489	CbGeAlD
Loperamide—CALM1—central nervous system—Behcet's disease	0.0032	0.00486	CbGeAlD
Loperamide—CALM2—brain—Behcet's disease	0.00255	0.00388	CbGeAlD
Loperamide—CALM1—brain—Behcet's disease	0.00254	0.00386	CbGeAlD
Loperamide—CYP2B6—nervous system—Behcet's disease	0.00248	0.00377	CbGeAlD
Loperamide—ABCB1—retina—Behcet's disease	0.00244	0.00371	CbGeAlD
Loperamide—CYP2B6—central nervous system—Behcet's disease	0.00239	0.00363	CbGeAlD
Loperamide—CYP2C8—brain—Behcet's disease	0.00212	0.00321	CbGeAlD
Loperamide—ABCB1—mammalian vulva—Behcet's disease	0.00196	0.00297	CbGeAlD
Loperamide—CYP2B6—brain—Behcet's disease	0.0019	0.00288	CbGeAlD
Loperamide—CYP3A4—nervous system—Behcet's disease	0.00187	0.00285	CbGeAlD
Loperamide—CYP2D6—nervous system—Behcet's disease	0.00184	0.0028	CbGeAlD
Loperamide—CYP3A4—central nervous system—Behcet's disease	0.0018	0.00274	CbGeAlD
Loperamide—CYP2D6—central nervous system—Behcet's disease	0.00178	0.0027	CbGeAlD
Loperamide—ABCB1—medulla oblongata—Behcet's disease	0.00177	0.00268	CbGeAlD
Loperamide—ABCB1—midbrain—Behcet's disease	0.00161	0.00245	CbGeAlD
Loperamide—ABCB1—spinal cord—Behcet's disease	0.00157	0.00239	CbGeAlD
Loperamide—CYP2D6—brain—Behcet's disease	0.00141	0.00214	CbGeAlD
Loperamide—ABCB1—nervous system—Behcet's disease	0.00133	0.00202	CbGeAlD
Loperamide—ABCB1—central nervous system—Behcet's disease	0.00128	0.00194	CbGeAlD
Loperamide—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.00113	0.00329	CbGpPWpGaD
Loperamide—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.00112	0.00329	CbGpPWpGaD
Loperamide—POMC—GPCR ligand binding—CXCL8—Behcet's disease	0.00112	0.00328	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.00112	0.00327	CbGpPWpGaD
Loperamide—CALM1—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.0011	0.0032	CbGpPWpGaD
Loperamide—CALM2—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.0011	0.0032	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.00106	0.00311	CbGpPWpGaD
Loperamide—CALM3—Diseases associated with visual transduction—APOA1—Behcet's disease	0.00104	0.00303	CbGpPWpGaD
Loperamide—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—Behcet's disease	0.00103	0.003	CbGpPWpGaD
Loperamide—ABCB1—brain—Behcet's disease	0.00101	0.00154	CbGeAlD
Loperamide—OPRD1—GPCR downstream signaling—CCR1—Behcet's disease	0.001	0.00293	CbGpPWpGaD
Loperamide—CALM1—Diseases associated with visual transduction—APOA1—Behcet's disease	0.001	0.00293	CbGpPWpGaD
Loperamide—CALM2—Diseases associated with visual transduction—APOA1—Behcet's disease	0.001	0.00293	CbGpPWpGaD
Loperamide—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—Behcet's disease	0.000992	0.0029	CbGpPWpGaD
Loperamide—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—Behcet's disease	0.000992	0.0029	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—MEFV—Behcet's disease	0.000945	0.00276	CbGpPWpGaD
Loperamide—CALM3—Platelet degranulation—SERPINE1—Behcet's disease	0.000944	0.00276	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—MEFV—Behcet's disease	0.000914	0.00267	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—MEFV—Behcet's disease	0.000914	0.00267	CbGpPWpGaD
Loperamide—CALM2—Platelet degranulation—SERPINE1—Behcet's disease	0.000913	0.00267	CbGpPWpGaD
Loperamide—CALM1—Platelet degranulation—SERPINE1—Behcet's disease	0.000913	0.00267	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CCR1—Behcet's disease	0.00091	0.00266	CbGpPWpGaD
Loperamide—CALM3—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.000899	0.00263	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—CCR1—Behcet's disease	0.000879	0.00257	CbGpPWpGaD
Loperamide—OPRD1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.000872	0.00255	CbGpPWpGaD
Loperamide—CALM1—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00087	0.00254	CbGpPWpGaD
Loperamide—CALM2—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00087	0.00254	CbGpPWpGaD
Loperamide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.000834	0.00244	CbGpPWpGaD
Loperamide—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	0.00081	0.00237	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ERAP1—Behcet's disease	0.000809	0.00237	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CCR1—Behcet's disease	0.000798	0.00233	CbGpPWpGaD
Loperamide—POMC—Metabolism of proteins—CXCL8—Behcet's disease	0.000789	0.00231	CbGpPWpGaD
Loperamide—POMC—Metabolism—CAT—Behcet's disease	0.000788	0.0023	CbGpPWpGaD
Loperamide—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	0.000784	0.00229	CbGpPWpGaD
Loperamide—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	0.000784	0.00229	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ERAP1—Behcet's disease	0.000783	0.00229	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ERAP1—Behcet's disease	0.000783	0.00229	CbGpPWpGaD
Loperamide—POMC—Metabolism—APOB—Behcet's disease	0.000765	0.00224	CbGpPWpGaD
Loperamide—OPRK1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.000765	0.00224	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—CCR1—Behcet's disease	0.000743	0.00217	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—HLA-B—Behcet's disease	0.000736	0.00215	CbGpPWpGaD
Loperamide—OPRD1—G alpha (i) signalling events—CXCL8—Behcet's disease	0.000736	0.00215	CbGpPWpGaD
Loperamide—CALM1—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.000726	0.00212	CbGpPWpGaD
Loperamide—CALM2—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.000726	0.00212	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—NOS3—Behcet's disease	0.000714	0.00209	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—HLA-B—Behcet's disease	0.000712	0.00208	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—HLA-B—Behcet's disease	0.000712	0.00208	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—ITGB2—Behcet's disease	0.000692	0.00202	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—NOS3—Behcet's disease	0.000691	0.00202	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—NOS3—Behcet's disease	0.000691	0.00202	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—CAT—Behcet's disease	0.000681	0.00199	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CCR1—Behcet's disease	0.000675	0.00197	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—NOS3—Behcet's disease	0.000674	0.00197	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—ITGB2—Behcet's disease	0.00067	0.00196	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—ITGB2—Behcet's disease	0.00067	0.00196	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—APOB—Behcet's disease	0.000661	0.00193	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—NOS3—Behcet's disease	0.000652	0.00191	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—NOS3—Behcet's disease	0.000652	0.00191	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—Behcet's disease	0.000649	0.0019	CbGpPWpGaD
Loperamide—OPRM1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.000646	0.00189	CbGpPWpGaD
Loperamide—OPRK1—G alpha (i) signalling events—CXCL8—Behcet's disease	0.000645	0.00189	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—APOB—Behcet's disease	0.00064	0.00187	CbGpPWpGaD
Loperamide—POMC—GPCR downstream signaling—CXCL8—Behcet's disease	0.000634	0.00185	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—Behcet's disease	0.000628	0.00184	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—Behcet's disease	0.000628	0.00184	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—ITGAL—Behcet's disease	0.000624	0.00183	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—ITGB2—Behcet's disease	0.000623	0.00182	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000612	0.00179	CbGpPWpGaD
Loperamide—POMC—Metabolism—APOA1—Behcet's disease	0.000605	0.00177	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—ITGAL—Behcet's disease	0.000604	0.00177	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—ITGAL—Behcet's disease	0.000604	0.00177	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—ITGB2—Behcet's disease	0.000603	0.00176	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—ITGB2—Behcet's disease	0.000603	0.00176	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ITGB2—Behcet's disease	0.000598	0.00175	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000585	0.00171	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ITGB2—Behcet's disease	0.000579	0.00169	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ITGB2—Behcet's disease	0.000579	0.00169	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—CXCL8—Behcet's disease	0.000576	0.00168	CbGpPWpGaD
Loperamide—CALM3—Alzheimers Disease—TNF—Behcet's disease	0.000562	0.00164	CbGpPWpGaD
Loperamide—CALM3—Immune System—MEFV—Behcet's disease	0.000551	0.00161	CbGpPWpGaD
Loperamide—OPRM1—G alpha (i) signalling events—CXCL8—Behcet's disease	0.000545	0.00159	CbGpPWpGaD
Loperamide—CALM1—Alzheimers Disease—TNF—Behcet's disease	0.000543	0.00159	CbGpPWpGaD
Loperamide—CALM2—Alzheimers Disease—TNF—Behcet's disease	0.000543	0.00159	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ITGAL—Behcet's disease	0.00054	0.00158	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CCR1—Behcet's disease	0.000538	0.00157	CbGpPWpGaD
Loperamide—CALM1—Immune System—MEFV—Behcet's disease	0.000533	0.00156	CbGpPWpGaD
Loperamide—CALM2—Immune System—MEFV—Behcet's disease	0.000533	0.00156	CbGpPWpGaD
Loperamide—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—Behcet's disease	0.000531	0.00155	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000527	0.00154	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—APOA1—Behcet's disease	0.000523	0.00153	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ITGAL—Behcet's disease	0.000522	0.00153	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ITGAL—Behcet's disease	0.000522	0.00153	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.000517	0.00151	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.000517	0.00151	CbGpPWpGaD
Loperamide—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—Behcet's disease	0.000513	0.0015	CbGpPWpGaD
Loperamide—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—Behcet's disease	0.000513	0.0015	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000513	0.0015	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00051	0.00149	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00051	0.00149	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—APOA1—Behcet's disease	0.000506	0.00148	CbGpPWpGaD
Loperamide—CALM3—Immune System—ERAP1—Behcet's disease	0.000491	0.00144	CbGpPWpGaD
Loperamide—CALM1—Immune System—ERAP1—Behcet's disease	0.000475	0.00139	CbGpPWpGaD
Loperamide—CALM2—Immune System—ERAP1—Behcet's disease	0.000475	0.00139	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CCR1—Behcet's disease	0.000472	0.00138	CbGpPWpGaD
Loperamide—POMC—Metabolism—NOS3—Behcet's disease	0.000459	0.00134	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—CXCL8—Behcet's disease	0.000445	0.0013	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000433	0.00127	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000426	0.00125	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000419	0.00122	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CCR1—Behcet's disease	0.000418	0.00122	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000405	0.00118	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000405	0.00118	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CCR1—Behcet's disease	0.000404	0.00118	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CCR1—Behcet's disease	0.000404	0.00118	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—SERPINE1—Behcet's disease	0.000402	0.00117	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCR1—Behcet's disease	0.000399	0.00117	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—NOS3—Behcet's disease	0.000396	0.00116	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—CXCL8—Behcet's disease	0.000391	0.00114	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—NOS3—Behcet's disease	0.000384	0.00112	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CTLA4—Behcet's disease	0.000371	0.00109	CbGpPWpGaD
Loperamide—CALM3—Immune System—ITGB2—Behcet's disease	0.000363	0.00106	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CTLA4—Behcet's disease	0.000359	0.00105	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CTLA4—Behcet's disease	0.000359	0.00105	CbGpPWpGaD
Loperamide—CALM2—Immune System—ITGB2—Behcet's disease	0.000351	0.00103	CbGpPWpGaD
Loperamide—CALM1—Immune System—ITGB2—Behcet's disease	0.000351	0.00103	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—APOB—Behcet's disease	0.000343	0.001	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—CXCL8—Behcet's disease	0.00034	0.000995	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—APOB—Behcet's disease	0.000332	0.000972	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—APOB—Behcet's disease	0.000332	0.000972	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—CXCL8—Behcet's disease	0.00033	0.000965	CbGpPWpGaD
Loperamide—CALM3—Immune System—ITGAL—Behcet's disease	0.000327	0.000957	CbGpPWpGaD
Loperamide—CALM1—Immune System—ITGAL—Behcet's disease	0.000317	0.000926	CbGpPWpGaD
Loperamide—CALM2—Immune System—ITGAL—Behcet's disease	0.000317	0.000926	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—HLA-B—Behcet's disease	0.000286	0.000837	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—HLA-B—Behcet's disease	0.000277	0.000809	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—HLA-B—Behcet's disease	0.000277	0.000809	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-B—Behcet's disease	0.000275	0.000804	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000272	0.000796	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—APOA1—Behcet's disease	0.000272	0.000795	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-B—Behcet's disease	0.000266	0.000777	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-B—Behcet's disease	0.000266	0.000777	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—APOA1—Behcet's disease	0.000263	0.000769	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—APOA1—Behcet's disease	0.000263	0.000769	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—APOB—Behcet's disease	0.000254	0.000742	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000252	0.000736	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCR1—Behcet's disease	0.000247	0.000722	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCR1—Behcet's disease	0.000239	0.000698	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCR1—Behcet's disease	0.000239	0.000698	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CXCL8—Behcet's disease	0.000229	0.000668	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000225	0.000659	CbGpPWpGaD
Loperamide—CALM3—Immune System—CTLA4—Behcet's disease	0.000225	0.000659	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ICAM1—Behcet's disease	0.000223	0.000653	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—APOB—Behcet's disease	0.000223	0.000651	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000221	0.000645	CbGpPWpGaD
Loperamide—CALM2—Immune System—CTLA4—Behcet's disease	0.000218	0.000637	CbGpPWpGaD
Loperamide—CALM1—Immune System—CTLA4—Behcet's disease	0.000218	0.000637	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ICAM1—Behcet's disease	0.000216	0.000632	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ICAM1—Behcet's disease	0.000216	0.000632	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—SERPINE1—Behcet's disease	0.000216	0.000631	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000215	0.000629	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.00021	0.000615	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—SERPINE1—Behcet's disease	0.000209	0.00061	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—SERPINE1—Behcet's disease	0.000209	0.00061	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NOS3—Behcet's disease	0.000206	0.000602	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—APOA1—Behcet's disease	0.000201	0.000587	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CXCL8—Behcet's disease	0.0002	0.000586	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NOS3—Behcet's disease	0.000199	0.000583	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NOS3—Behcet's disease	0.000199	0.000583	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—APOB—Behcet's disease	0.000188	0.00055	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000187	0.000545	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000178	0.000521	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—APOA1—Behcet's disease	0.000176	0.000515	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CXCL8—Behcet's disease	0.000169	0.000495	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-B—Behcet's disease	0.000167	0.000487	CbGpPWpGaD
Loperamide—CALM3—Disease—APOB—Behcet's disease	0.000166	0.000486	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-B—Behcet's disease	0.000161	0.000471	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-B—Behcet's disease	0.000161	0.000471	CbGpPWpGaD
Loperamide—CALM2—Disease—APOB—Behcet's disease	0.000161	0.00047	CbGpPWpGaD
Loperamide—CALM1—Disease—APOB—Behcet's disease	0.000161	0.00047	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SERPINE1—Behcet's disease	0.000159	0.000466	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NOS3—Behcet's disease	0.000152	0.000445	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—APOA1—Behcet's disease	0.000149	0.000435	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CAT—Behcet's disease	0.000147	0.000431	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CAT—Behcet's disease	0.000143	0.00042	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOB—Behcet's disease	0.000143	0.000419	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SERPINE1—Behcet's disease	0.00014	0.000409	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOB—Behcet's disease	0.000139	0.000407	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CAT—Behcet's disease	0.000139	0.000406	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CAT—Behcet's disease	0.000139	0.000406	CbGpPWpGaD
Loperamide—CALM3—Immune System—ICAM1—Behcet's disease	0.000135	0.000396	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CXCL8—Behcet's disease	0.000135	0.000395	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOB—Behcet's disease	0.000135	0.000394	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOB—Behcet's disease	0.000135	0.000394	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NOS3—Behcet's disease	0.000133	0.00039	CbGpPWpGaD
Loperamide—CALM3—Disease—APOA1—Behcet's disease	0.000132	0.000385	CbGpPWpGaD
Loperamide—CALM2—Immune System—ICAM1—Behcet's disease	0.000131	0.000383	CbGpPWpGaD
Loperamide—CALM1—Immune System—ICAM1—Behcet's disease	0.000131	0.000383	CbGpPWpGaD
Loperamide—CALM2—Disease—APOA1—Behcet's disease	0.000127	0.000372	CbGpPWpGaD
Loperamide—CALM1—Disease—APOA1—Behcet's disease	0.000127	0.000372	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CAT—Behcet's disease	0.000125	0.000365	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOB—Behcet's disease	0.000121	0.000354	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CXCL8—Behcet's disease	0.000118	0.000346	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SERPINE1—Behcet's disease	0.000118	0.000346	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOB—Behcet's disease	0.000116	0.000341	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOA1—Behcet's disease	0.000113	0.000331	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOS3—Behcet's disease	0.000113	0.00033	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOB—Behcet's disease	0.000113	0.000329	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOB—Behcet's disease	0.000113	0.000329	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOA1—Behcet's disease	0.00011	0.000322	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAT—Behcet's disease	0.000109	0.000318	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOA1—Behcet's disease	0.000107	0.000312	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOA1—Behcet's disease	0.000107	0.000312	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOB—Behcet's disease	0.000106	0.000309	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CXCL8—Behcet's disease	0.000105	0.000307	CbGpPWpGaD
Loperamide—CALM3—Disease—SERPINE1—Behcet's disease	0.000104	0.000305	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAT—Behcet's disease	0.000102	0.0003	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CXCL8—Behcet's disease	0.000101	0.000297	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CXCL8—Behcet's disease	0.000101	0.000297	CbGpPWpGaD
Loperamide—CALM2—Disease—SERPINE1—Behcet's disease	0.000101	0.000295	CbGpPWpGaD
Loperamide—CALM1—Disease—SERPINE1—Behcet's disease	0.000101	0.000295	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CXCL8—Behcet's disease	0.0001	0.000293	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS3—Behcet's disease	9.97e-05	0.000292	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOB—Behcet's disease	9.95e-05	0.000291	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS3—Behcet's disease	9.65e-05	0.000282	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS3—Behcet's disease	9.65e-05	0.000282	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOA1—Behcet's disease	9.59e-05	0.00028	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOA1—Behcet's disease	9.21e-05	0.000269	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOA1—Behcet's disease	8.91e-05	0.000261	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOA1—Behcet's disease	8.91e-05	0.000261	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—Behcet's disease	8.58e-05	0.000251	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—Behcet's disease	8.35e-05	0.000244	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOA1—Behcet's disease	8.35e-05	0.000244	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—Behcet's disease	8.08e-05	0.000236	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—Behcet's disease	8.08e-05	0.000236	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOA1—Behcet's disease	7.87e-05	0.00023	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—Behcet's disease	7.31e-05	0.000214	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—Behcet's disease	7.26e-05	0.000212	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—Behcet's disease	7.07e-05	0.000207	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—Behcet's disease	7.07e-05	0.000207	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—Behcet's disease	6.98e-05	0.000204	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—Behcet's disease	6.75e-05	0.000198	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—Behcet's disease	6.75e-05	0.000198	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAT—Behcet's disease	6.7e-05	0.000196	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOB—Behcet's disease	6.5e-05	0.00019	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—Behcet's disease	6.33e-05	0.000185	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL8—Behcet's disease	6.19e-05	0.000181	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL8—Behcet's disease	5.99e-05	0.000175	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL8—Behcet's disease	5.99e-05	0.000175	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—Behcet's disease	5.96e-05	0.000174	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOA1—Behcet's disease	5.14e-05	0.00015	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—Behcet's disease	3.9e-05	0.000114	CbGpPWpGaD
